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A patient diagnosed with a glioma generally has an average of 14 months 
to live after implementation of conventional  therapies such as surgery, 
chemotherapy, and radiation. Glioblastomas are highly lethal because of their 
aggressive nature and resistance to conventional therapies and apoptosis. Thus 
other avenues of cell death urgently need to be explored. Autophagy, which is 
also known as programmed cell death type II, has recently been identified as an 
alternative mechanism to kill apoptosis-resistant cancer cells. Traditionally, 
researchers have studied how cells undergo autophagy during viral infection as 
an immune response mechanism, but recently researchers have discovered how 
viruses have evolved to manipulate autophagy for their benefit. Extensive studies 
of viral-induced autophagy provide a rationale to investigate other viruses, such 
as the adenovirus, which may be developed as part of a therapy against cancers 
resistant to apoptosis. Despite the present and relatively poor understanding of 
the   mechanisms behind adenoviral-induced autophagy,   adenovirus is a 
promising candidate, because of its ability to efficiently eradicate tumors. A better 
understanding of how the adenovirus induces autophagy will allow for the 
development of viruses with increased oncolytic potency.  We hypothesized that 
adenovirus induces autophagy in order to aid in lysis.  We found that replication, 
vii
 
 
not infection, was required for adenovirus-mediated autophagy. Loss of function 
analysis of early genes revealed that, of the early genes tested, no single gene 
alone was sufficient to induce autophagy.  Examination of cellular pathways for 
their role in autophagy during adenovirus infection revealed a function for the 
eIF2α pathway and more specifically the GCN2 kinase. Cells lacking GCN2 are 
more resistant to adenovirus-mediated autophagy in vitro; in vivo we also found 
these cells fail to undergo autophagy, but display more cell death.  We believe 
that autophagy is a protective mechanism the cell employs during adenoviral 
infection, and in the in vivo environment, cells cannot recover from virus infection 
and are more susceptible to death. Congruently, infected cells deficient for 
autophagy through deletion of ATG5 are not able to undergo productive cell lysis, 
providing evidence that the destruction of the cytoplasm and cell membrane 
through autophagy is crucial to the viral life cycle. This project is the first to 
describe a gene, other than a named autophagy gene, to be required for 
adenovirus-mediated autophagy. It is also the first to examine autophagic cell 
death as a means to aid in viral-induced cell lysis. 
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Chapter One: Introduction 
 
 
 
 
 
The tribulations of glioma therapy 
 
While there have been many advancements in some cancers, no such 
exciting discoveries have been made for glioma therapy in the past 25 years (1). 
Glioblastomas are infamous because of their aggressive nature and resistance to 
conventional cytotoxic injuries, such as radiation and chemotherapy (2).  Survival 
data on glioma patients reveals that after chemotherapy, radiation, and surgical 
resection, the patient only has a life expectancy of fourteen months, and most 
succumb to their illness within two years (1). In fact, due to the high rates of 
mortality,  malignant  gliomas  are  the  first  leading  cause  of  cancer  death  in 
children, the third leading cause of cancer-related death among men 15-54 and 
the fourth for women 15-34 years of age. Gliomas are resistant to apoptosis; thus 
new modes of cell death must be explored. 
 
 
 
Autophagy 
 
Autophagy is a basal process that is essential to normal function of life. 
Autophagy is a cellular process the cell undergoes in response to stresses, such 
as starvation and pathogen infection (reviewed by (3)). The cell digests proteins 
and  organelles  to  provide  energy  for  homeostatic  function  and  catabolic 
processes (reviewed by (3)). The cell has internal sensors for monitoring energy 
and nutrient levels and, in turn, regulates protein translation and autophagy in 
response to any changes. 
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Autophagy is a crucial process in order to function properly.  Defective 
autophagy has been demonstrated to have detrimental effects for multiple 
species, such as Saccharomyces cerevisiae (4) Dictyostelium discoideum   (5), 
Drosophila  melanogaster  (6,  7),  and  Caenorhabditis  elegans  (8)  . Two 
autophagy genes have been extensively studied for their role in embryogenesis, 
Atg5 and Becn1.  Mice null for an essential gene, Atg5, die within 12 hours of 
birth, if starved, versus around 21 hours for the wild-type mice (9). However, 
homozygous deletion of Beclin 1 causes mice to die at embryonic day 7.5 (10). 
There are two main biochemical markers that scientists can use to monitor 
autophagy in higher eukaryotes: LC3, and p62 (11, 12).  ATG5 has been shown 
to be an indicator of autophagy during adenovirus infection (13).  ATG5 almost 
exclusively exists in a covalently bound complex to ATG12 (14). ATG12 is 
bound to ATG5 through the actions of the ubiquitin E1 and E2-like ligases, ATG7 
and ATG10, respectively (14, 15). ATG5/12 then associates with ATG16 in an 
800kDa complex and localizes to the phagophore (16).  The localization of the 
complex is required for the recruitment of LC3 to the phagophore. 
LC3 is the most common protein used to monitor autophagy.  LC3 exists 
primarily in two forms: LC3-I and LC3-II.  The LC3-I, and is cleaved by ATG4 to 
the mature form LC3-II. LC3-II is subsequently lipidated to a 
phosphotidylethanoamine by an E2-like enzyme Atg7 and incorporated into the 
phagophore (17).  Scientists can monitor the cleavage of LC3-I to LC3-II through 
western blotting or by analyzing cellular localization of fluorescent tagged LC3 
(11).  p62, along with LC-3, binds poly-ubiquinated proteins and directs them to 
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the autophagosome to be degraded (18, 19). p62 is then subsequently degraded 
by the autophagolysosome. 
 
 
 
Autophagy during the viral life cycle 
 
Autophagy during virus infection has largely been associated with viral 
clearance and major histocompatibility complex type II antigen presentation (20). 
Recently, the viral-associated autophagy field has diverged to also explore how 
viruses have hijacked this evolutionarily conserved process in order to aid in 
replication. (+) RNA viruses, which replicate in the cytoplasm, manipulate 
intracellular membrane structures to form replication complexes (reviewed by 
(21)). Dengue  virus,  equine  arteritis  virus,  and  mouse  hepatitis  virus  all 
colocalize at sites of DNA replication with double-membrane vesicles in the 
cytoplasm ((22-24) reviewed by (21)).  LC3 was shown to colocalize with virus- 
induced vesicles leading researchers to agree that these were, in fact, 
autophagosomes (23, 24). Mouse hepatitis virus yields fall by a factor of 1000 in 
the absence of ATG5 (23). On the other hand, human cytomegalovirus, HIV 
Type I and herpes simplex virus must thwart autophagy in order to have a 
productive  viral  life  cycle  (20,  25,  26). Five  labs,  including  ours,  have 
demonstrated that adenovirus  is  associated  with  autophagy  (13,  27-31).  We 
propose that in contrast to the RNA viruses, adenovirus is a DNA virus that 
replicates in the nucleus; therefore it should not utilize cytoplasmic located 
autophagosomes for replication scaffolds; furthermore suggesting that the 
adenovirus-induced autophagy serves a distinct justification and constitutes a 
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separate regulatory mechanism.  Since autophagy is associated with adenoviral 
replication, we believe that autophagy is beneficial for adenovirus and must serve 
some  purpose.  Our  theory  suggests  that  adenovirus  replication  leads  to 
excessive consumption of ATP and amino acids, generating a potential deficit of 
energy resulting in the triggering of autophagy to generate materials for 
adenovirus replication. Autophagy has been speculated as a mechanism to 
provide the cell with ATP during stressful times (32). 
 
 
 
Adenovirus 
 
Adenovirus is a common virus that most humans develop immunity to by 
the time they reach adolescence. Adenovirus causes acute upper respiratory 
infections and conjunctivitis (33-35). There are 51 different human adenovirus 
serotypes (36-38).  The studies here are based upon Class C Adenovirus type 5, 
a non-oncogenic adenovirus. Adenovirus is an encapsidated, double-stranded 
DNA virus (38).  Adenovirus encodes 34 proteins from both strands of DNA.  The 
genome holds three transcription groups: early transcription genes, delayed 
transcription genes, and late transcription (38). Replication is broken down into 
three stages.  The first 2-4 hours of after infection is deemed the immediate-early 
infection. This is when E1 (E1A, E1B55K, and E1B19K) is expressed. From 
hours 4-12 is early infection. E2, E3, and E4 are expressed.  After 12 hours is 
considered late infection.  The transcription and translation is focused on capsid 
proteins. 
5
 
 
The Delta-24-RGD voyage from bench to bedside 
 
Delta-24 has a 24-nucleotide deletion that renders it unable to bind to E1A 
(39). This virus cannot replicate in cells with a competent Rb pathway, which 
makes it cancer specific.  Second  generation  Delta-24,  Delta-24-RGD,  has  a 
RGD-4C sequence inserted in the HI loop of the fiber knob (40). Glioma cells are 
known to have increased amounts of RGD-binding integrins on their surface, an 
observation  exploited  by  Delta-24-RGD,  whose  RGD  domain  increases  its 
binding efficiency to gliomas. Delta-24-RGD has been a successful anticancer 
therapy in osteosarcoma, lung, prostate, cervical, and ovarian cancer cell lines 
(31, 41-44). Delta-24-RGD has recently been administered to patients in Phase I 
clinical trials in M. D. Anderson Cancer Center, and furthermore, it is being tested 
in  the  University  of  Alabama-Birmingham  for  ovarian  cancer  (45).  Previous 
studies focused on the ability of Delta-24-RGD to kill cancer cells (13, 28, 29), 
and this study is unique because it will focus on mechanistic studies underlying 
Delta-24-RGD and wild-type adenovirus-mediated autophagy by manipulating 
and enhancing cell death to increase the antiglioma effect. 
 
 
 
 
 
 
 
 
 
 
 
Potential Interactions of Adenoviral Early Genes in the Role of Autophagy 
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Figure 1: Proposed interactions of adenovirus early proteins and their potential 
interaction with proteins/pathways involved in autophagy. 
 
Adenovirus  has  many  potential  genes  that  may  be  responsible  for 
inducing  autophagy  (figure  1). Primarily,  adenoviral  proteins  are  expressed 
either as early genes or late genes. Early gene E1A  binds to the retinoblastoma 
protein and is necessary for the virus to replicate (46).  Loss of E1 renders the 
virus unable to replicate.  Early gene E1B19K is a Bcl-2 homolog responsible for 
the  inhibition  of  apoptosis  (47).  We  hypothesize  that  E1B19K  disrupts  the 
balance  of  Bcl-2  binding  to  Beclin  1,  thus  favoring  autophagy. Early  gene 
E1B55K binds to p53 to inhibit apoptosis and p53 is a known upstream regulator 
7
 
 
of DRAM (48) (49). E3 is associated with cell death (50, 51).  E4 is necessary for 
host cell shutoff, late gene expression, and DNA replication (52). E4 is also 
associated with mTOR activation (53). It has been shown that E4-ORF-1 and 
E4-ORF-4 from adenovirus are able to mimic the growth factor signals by 
activating PI3-kinase, thus activation of mTOR (53). mTOR is an important 
regulator of cell growth. It serves as the cells’ sensor for nutrient and growth 
factor signals (53).  Adenoviral VA RNA binds to and blocks the activation PKR 
(54) which is also a regulator of autophagy (55). Our goal is to elucidate the 
mechanism in which adenovirus triggers autophagy in the host cell. 
 
 
 
 
 
Bioenergy Sensing pathways and Autophagy 
 
 
“Whole-body energy metabolism” is an extremely delicate process with 
multiple checks and balances (Steinberg, G., et al., 2009). The body uses 
different cytokine signals to communicate energy needs in each tissue. On a 
cellular level, AMP-activated protein kinase (AMPK) has been identified as the 
translator of these extracellular signals (reviewed by (56)). AMPK is charged 
with regulating metabolism based on energy demand and supply within the cell. 
In  times  of  nutrient  deficiency,  AMPK  inhibits  growth  primarily  by  exerting 
inhibition  over  the  master  growth  regulating  kinase  mTOR  (57). AMPK  is 
involved  in  other  equally  valuable  functions  of  the  cell,  such  as  regulating 
polarity, cell structure, and fatty-acid production (reviewed by (58)). 
 
LKB1 regulation of AMPK 
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On the road to discovering the genetic principle behind the familial disease, 
Peutz-Jeghers syndrome, researchers in Finland found the gene LKB1 to be 
inactively mutated in most patients (59). This was the first description of a 
cancer-susceptibility syndrome caused by inactivation of a protein kinase (59). 
LKB1 is classically known as the sensor of metabolic energy and maintaining 
homeostasis in the cell by activating AMPK (60), but it is also responsible for 
positively regulating 13 other proteins in the AMPK-related family of kinases also 
essential in regulating cellular polarity and structure (61). LKB1 distinguishes 
between  these  responsibilities  by  delegating  AMPKα  and  SIK  in  regulating 
energy homeostasis and eliciting MARK proteins, SAD proteins, and AMPKα2 to 
regulate cell polarity and structure. LKB1 activates the downstream kinases via 
direct  phosphorylation  in  their  activation  loops  (reviewed  by  (58)).  LKB1 
activates  AMPK  by  phosphorylation  of  Threonine  172  (Thr172). AMPK 
propagates the signal through phosphorylation of downstream substrates 
(reviewed by (62)). 
 
 
 
 
 
AMPK 
 
 
AMPK is a heterotrimeric protein consisting of a catalytic α domain and 
regulatory  β  and  γ  subunits  (63). AMPK  binds  to  AMP  and  ATP  in  the 
cystathionine-β-synthase domain of the γ domain. The α and γ subunits are 
tethered together via the β subunit (63).  Upon binding AMP, AMPK undergoes a 
conformational  change  allowing  phosphorylation  of  Thr172  by  an  upstream 
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kinase;  however,  binding  ATP  does  not  produce  a  conformational  change, 
subsequently inhibiting upstream kinase-mediated phosphorylation (64). 
 
Of  many  responsibilities,  AMPK  specifically  regulates  autophagy,  cell 
growth, and protein translation through inhibition of mTOR.  Specifically, AMPK 
inhibits mTOR by phosphorylation of the upstream inhibitor of mTOR, TSC1/2. 
AMPK can also directly inhibit mTOR by phosphorylating raptor, a subunit of the 
mTORC1 complex (reviewed by Hezel (58)).  A more robust description of mTOR 
regulation is discussed below. 
 
 
 
 
 
TSC1/2 
 
 
TSC1 and TSC2 were identified as tumor suppressors in the 90s after 
isolating the genetic loci frequently mutated in the autosomal dominant syndrome 
TSC that causes multiple benign tumors (65).  TSC1/2 exists in a heterodimeric 
complex  essential  to  prevent  ubiquitin-mediated  degradation. While,  TSC2 
contains the enzymatic GAP activity, TSC1 is required to stabilize TSC2.   The 
TSC1/2 complex often has mutations in the GAP domain of TSC2 or mutations in 
TSC1 that lead to destabilization, and both of which are regularly causes of the 
TSC disease (reviewed by (65)).  TSC1/2 are activated by numerous pathways, 
including the PI3K-AKT, ERK-RSK, and LKB1-AMPK pathways.  After activation 
through LKB1, AMPK propagates its signal though TSC1/2 via phosphorylation of 
TSC2 on Serine 1387 and Threonine 1271, subsequently stimulating TSC2 GAP 
activity (66).  The complex mode of action during the phosphorylation of TSC2 is 
10
 
 
not entirely known, however, it is known that TSC2 mediates its effects through 
negatively regulating the GAP activity of Rheb (reviewed by (65)). When the 
GAP activity of TSC2 is stimulated, it converts the GTP-bound form of Rheb to 
the GDP-bound form, however Akt activation is opposite. Akt phosphorylates 
TSC2 at a different site from AMPK phosphorylation to inhibit the GAP activity of 
Rheb, therefore stimulating mTOR activity. 
 
 
 
 
 
mammalian Target of Rapamycin 
 
 
mTOR is a 240kDa protein that can exist in two complexes: mTORC1 and 
mTORC2.  mTORC1 consists of mTOR, raptor, mLST8, PRAS40 while mTORC2 
consists of mTOR, rictor, mLST8, and SIN1 (67, 68). mTORC2, is primarily 
associated with actin organization and feedback inhibition of Akt and is not 
relevant,  with  respect  to  AMPK  regulation. mTORC1  is  responsible  for  the 
regulation of protein translation in response to growth factors and nutrient 
availability, and autophagy as well. In order for mTORC1 to have maximal 
catalytic activity it must be associated with GTP-bound Rheb.  Rheb is only in the 
GTP-bound state when TSC2 GAP activity is suppressed, such as Akt activation. 
When Rheb binds to mTOR, mTORC1 positively regulates the phosphorylation of 
two effectors, S6K (p70S6 kinase) and 4E-BP1 (eukaryotic initiation factor 4E 
binding protein 1), which allow protein translation under favorable conditions (67). 
On the other hand, mTOR is also responsible for the phosphorylation of ULK-1 
and Atg13 to promote autophagy (69).  Under normal growth conditions, mTOR 
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is activated though the PI3K/Akt pathway resulting in cell growth. However, 
when nutrients are withdrawn, or AMPK is stimulated, mTOR is inhibited through 
activation of TSC1/2 which inhibits Rheb binding to mTOR eventually halting 
protein synthesis and inducing autophagy. 
 
 
 
 
eIF2α pathway in Autophagy 
 
eIF2α is a translation factor that is responsible for halting translation in 
response to cellular stresses.  There are four kinases that regulate eIF2α (figure 
2). PERK (70), GCN2 (71, 72), HRI (73), and PKR (74)(reviewed in (75)). eIF2a 
can selectively translate certain mRNAs based on which stressor it is responding 
to (reviewed in (76)).  Our focuses were mainly on GCN2 and PERK as HRI is 
mainly  a  tissue  specific   protein,   primarily   erythroid-specific   and   PKR   is 
inactivated by adenovirus (77, 78). 
 
 
 
 
 
Figure 2:  Upstream kinases that regulate eIF2α activity. 
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PERK 
 
PERK is activated upon ER stress, such as the unfolded protein response 
(70).  PERK then phosphorylates eIF2α to reduce global protein synthesis (79). 
However, during ER stress there is preferential translation of mRNA, such as 
ATF4  (80-83). ATF4  is  known  to  be  upregulated  by  the  unfolded  protein 
response, oxidative stress and amino acid starvation (79).  Continued ER stress 
can lead to the induction of autophagy (84, 85). Induction of autophagy is 
thought to help clear the unfold protein aggregates and aid in cell survival (85). 
 
 
GCN2 
 
GCN2 is an evolutionarily conserved kinase that was first identified in 
yeast (86). GCN2 is primarily a surveyor of intracellular amino acids and has 
been shown to be required for proper amino acid starvation adaptation in in vivo 
mouse models (72, 87).  GCN2 has a domain that binds to uncharged tRNAs that 
functions as a sensor for available amino acids (88, 89). When there is an 
abundance of uncharged tRNAs, GCN2 is activated and phosphorylates eIF2α to 
halt translation (88, 90). However, GCN2 can regulate protein translation in 
response to UV irradiation, as well (71).  GCN2 has been indicated in autophagy 
induction during amino acid starvation via an eIF2α dependent mechanism (55). 
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Chapter 2: Material and Methods 
 
 
 
 
 
Cell culture 
 
MRC-5 human fibroblasts, U251-MG, U87-MG, and HeLa cells were 
cultured in Dulbecco’s modified  Eagle medium/F12 medium    (1:1, v/v) 
supplemented with  10% fetal  bovine serum and  1% 
penicillin/streptomycin/amphotericin B  (Invitrogen, Carlsbad, CA). AMPKα1-/-α2-/- 
mouse embryonic fibroblasts (MEFs) (Keith Laderoute, SRI), 
GCN2-/- and WT MEFs (Douglas Cavener, PSU), PERK-/- and WT MEFs (David 
 
Ron, PSU) were cultured in Dulbecco’s modified Eagle medium (1:1, v/v) 
supplemented with 10% fetal bovine serum and 1% 
penicillin/streptomycin/amphotericin B. All cells were grown in a humidified 
atmosphere containing 5% CO2 at 37°C. 
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Viruses and Virus Propagation 
 
Table 1. 
 
 
 
 
Gene Mutation Virus Name Source Original Source 
 
E1-Deleted AdOLE/1.8 MDACC 
 
Adenoviral Core 
 
E3-Deleted Ad300 
 
 
E1A Mutation Delta-24 Juan Fueyo Athanassios P. 
 
Kyritsis (39) 
 
Fiber 
 
Modification 
Delta-24-RGD Ramon Alemany Ramon Alemany 
 
(42) 
 
E1B55K-Deleted dl1520/Onyx-O15 Ramon Alemany Frank  McCormick 
 
(91) 
 
E1B19K-Deleted Delta-E1B19K Our Laboratory Our Laboratory 
 
E4-Deleted dl366 Clodagh O’shea Tom Shenk (92) 
 
Delta-VA RNA Ad-VAdel Ramon Alemany Ramon Alemany 
 
(93) 
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Acidic Vesicular Organelles Analysis with Flow Cytometry 
 
 
 
 
2x105  cells were seeded in a 6 well plate. The same day cells were 
treated as indicated and incubated for 48-72 hours.   Acridine Orange (Sigma- 
Aldrich, St Louis, MO) was added to the cells for a final concentration of 1µg/ml 
and incubated for 15 minutes in the cell culture incubator. The media was 
collected  and  spun  at  14,000  RPM  for  20  seconds  the  supernatant  was 
aspirated.  Remaining cells were washed once with PBS, trypsinized, collected in 
PBS, and spun in the same tube as before. Cells were resuspended in 200-500µl 
of PBS. Samples were analyzed on a Becton Dickson Flow Cytometer with 
CellQuest software. 
 
 
 
 
Transfection 
 
 
U-87 MG cells were transiently transfected using FuGENE6 with either 
pCDNA3.1 empty vector or pCDNA3.1-12s E1A cDNA expressing vector (gift 
from Dr. Mein Chie Hung, MD Anderson Cancer Center, Houston, TX) per the 
vendors instructions. Cells were collected 48-96 hours after transfection and 
subjected to immunoblotting. 
 
U-87 MG cells were stably transfected using FuGENE6 with an eGFP-LC3 
expressing plasmid (Noburu Mizushima, Japan). The cells were selected with 
G418 at a concentration of 700µg/ml.  After selection the cells were plated at a 
concentration of 4x104 cells per well in Lab Tek II chamber slides (Cole-Parmer, 
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Vernon Hills, Illinois). Cells were infected as indicated and after 48 hours the 
media was aspirated and the cells were fixed in 4% paraformaldehyde for 30 
minutes at -20°C.  The cells were washed with PBS and mounted with ProLong 
Gold Antifade reagent with Dapi (Invitrogen, Carlsbad, CA).  Images of the cells 
were taken and processed on a Zeiss Axiovert Zoom fluorescence microscope 
(Carl Zeiss, Inc., Thornwood, NY, USA) equipped with AxioCam MRM camera 
and 40x 1.3 oil EC Plan-NEOFLUAR objective, using Immersol (n = 1.518) at 
room  temperature.  Acquisition software  was  AxioVision  Release  4.7.1  (Carl 
Zeiss, Inc.). 
 
Immunoblotting 
Cells  (1x106   in  a  10cm  dish)  were  treated  as  indicated. Samples 
containing 40µg of protein were subjected to 1.5 mm 12% or 6% SDS-Tris- 
glycine  gel  electrophoresis.  We  also  used  4-20%  Novex  gels  (Invitrogen, 
Carlsbad, CA). Proteins were transferred to Whatmann nitrocellulose 
membranes or PVDF membranes (Bio-Rad, Hercules, CA ) using a Bio-Rad 
Semi-Dry transfer machine at 25V for 30 minutes or 20V for 1 hour for larger 
proteins. Membranes were blocked in 10% Non-fat dry milk solubilized in 1x 
TBS-0.05% Tween-20.  Membranes were incubated overnight in 2% Nonfat dry 
milk in 1x TBS-0.05% Tween-20 with antibody.  Membranes were washed three 
times (15min, 5 min, 5 min) with 1x TBS-0.05% Tween-20. Antibody complexes 
were detected using chemiluminescence reagent (GE Amersham, Piscataway, 
NJ ) in accordance with the manufacturer's instructions. 
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Table 2. 
 
 
 
Antibody Dilution Company 
Atg5 1:2000 Cosmo Bio, Japan 
LC3 1:1000 Cell Signaling,  Danvers, MA 
p62 (WB) 1:200 Santa Cruz Biotechnology, Santa Cruz, CA 
eIF2α 1:1000 Cell Signaling,  Danvers, MA 
Phospho-eIF2α 1:1000 Cell Signaling, Danvers, MA 
Actin 1:4000 Santa Cruz Biotechnology, Santa Cruz, CA 
GCN2 1:1000 Cell Signaling, Danvers, MA 
Phospho-GCN2 1:1000 Cell Signaling,  Danvers, MA 
E1A 1:200 Santa Cruz Biotechnology, Santa Cruz, CA 
P62 (IF) 1:600 Sigma Aldrich, St. Louis, MO 
 
 
 
Electron Microscopy 
 
 
Cells were seeded in a ten centimeter dish (1-2x106) and infected at 100 
 
MOI. If indicated, cells were treated with Bafilomycin A1, a vacuolar ATPase 
inhibitor, (Sigma Aldrich, St. Louis, MO) at a concentration of 10nM.  Cells were 
collected and pelleted at 300 x g were rinsed with PBS and fixed in a solution 
containing 3% glutaraldehyde plus 2% paraformaldehyde 1% Millipore-filtered 
uranly  acetate. Samples  were  dehydrated  in  increasing  concentrations  of 
ethanol, infiltrated, and embedded in LX-112 medium. Samples were 
polymerized in a 70˚C oven for two days.  Ultra thin sections were cut in a Leica 
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Ultracut microtome (Leica, Deerfield, IL), stained with uranyl acetate and lead 
citrate in a Leica EM Stainer, and examined in a JEM 1010 transmission electron 
microscope (JOEL, USA, Inc., Peabody, MA) at an accelerating voltage of 80kV. 
Digital images were obtained using AMT Imaging System (Advanced Microscopy 
Techniques Corp, Danvers, MA). 
 
 
 
 
 
Crystal Violet Staining 
 
 
8.0x104 cells were seeded in a 24 well plate and infected with adenovirus 
as indicated.  96 hours later the media was aspirated, cells were washed with 
PBS, and stained with 0.05% Crystal Violet (Sigma, St Louis, MA) in 20% 
methanol for 10 minutes.  Cells were washed and crystal violet was solubilized 
with 1% SDS and read at a wavelength of 570nm. 
 
 
 
 
 
Quantitative Real Time-PCR 
 
 
Cells (1x106 per well in 10cm plates) were infected with wild type 
adenovirus type 5, with a MOI of 100.  Twenty hours after infection, cells were 
collected and mRNA was extracted using the RNeasy kit (Qiagen, Valencia, CA). 
Samples were subjected to the turbo DNA free kit to remove all traces of DNA 
(Ambion, Austin, TX) and sent to for the autophagy PCR array (SA Biosciences, 
Frederick, MD). 
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Antibody Kinase Array 
 
 
MRC5 cells were either mock infected or infected at a MOI of 100 and 
collected at 16, 32, or 48 hours post infection. Lysates were subjected to the 
human phospho-kinase array kit that was purchased from R&D Systems 
(Minneapolis, MN) and used according to the manufactures instructions. 
 
 
 
 
 
siRNA and shRNA technologies 
 
 
The pLKO.1 vector was a generous gift from Robert Weinberg, Whitehead 
Institute, Boston, MA.  7x105 HEK-293T cells were plated in 5ml of a 6cm culture 
dish. 24 hours later pLKO.1, psPAX2, and pMD2.G were cotransfected with 
FuGENE6 (Roche Diagnostics, Indianapolis, IN) for 15 hours.  48 hours later the 
media was collected and stored a 4°C and fresh media was added to the 
remaining cells.  24 hours later the media was collected again and combined with 
the previous media collected. The media was spun at 1,250 rpm for 5 minutes 
to pellet cell debris. The media-containing virus was stored at -80°C. The 
supernatant was used to infect 0.5x106 U251-MG cells. 8µg/ml of polybrene was 
added to the cells and 1ml of supernatant was added to the cells.  24 hours after 
infection 1µg/ml of puromycin was added for selection of infected cells. 
 
To knockdown ATG5, we purchased a shRNA-expressing plasmid from 
Origene (Rockville, MD, USA). We transfected the plasmids into the U87 cells 
with  FuGENE  6.  The  cells  were  screened,  and  stable  cell  clones  were 
maintained in culture medium plus 0.5 µg/ml puromycin. 
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Replication assays 
 
Cells were seeded at 4x104 in a 12 well plate and infected at 100 MOI for 
 
24 hours. The supernatant or cell extract was boiled at 95°C for 10 minutes and 
used as the DNA template. Platinum SybR Green (Invitrogen, Carlsbad, CA) 
was used as per manufactures instructions.  PCR was performed on a Bio-Rad 
iCycler with parameters: Cycle 1-95°C 5 mins, Cycle 2-30- 95°C 30s, 60°C 20s, 
and 70°C 20s. Cycle thresholds were compared to known quantities of the 
adenoviral genome in order to derive the genome copy number. 
 
 
 
Infectious Viral Particles 
 
Viral titer was assessed  using the  Adeno-X-Rapid Titer kit (BD 
Biosciences, Palo Alto, CA). Cells were subjected to three freeze thaw cycles to 
release the virus. The diluted virus was seeded over 1x105  293 cells in 24 well 
plates. The cells were fixed with methanol at -20°C for two minutes 48 hours later 
after infection. Cells were incubated at 37°C for two hours with goat anti-hexon in 
PBS containing 1% bovine serum albumin. Cells were washed 3 times with 
PBS+1% bovine serum albumin. Cells were incubated with goat conjugated 
HRP antibody (Vector Laboratories, Burlingame, CA) for two hours.  Cells were 
washed  3  times  with  PBS+  1%  BSA. HRP  substrate  was  added  per 
manufactures instructions (Vector Laboratories, Burlingame, CA).  Samples were 
developed using DAB tablets (Sigma-Aldrich, St. Louis, MO). Positive cells were 
be visualized on a compound light microscope. Mathematical equations are used 
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to derive the titer were calculated using the equation  from the Adeno-X-Rapid 
Titer kit (BD Biosciences, Palo Alto, CA). Briefly we calculated the number of 
fields in the objective, multiplied by the number of hexon positive cells, divided by 
the dilution factor, and multiplied by the volume of virus. 
 
 
 
Quantification of cell lysis 
 
 
The  cells  were  stained  with  8  µM  ethidium  homodimer  1  (Molecular 
Probes, Inc., Eugene, OR) in phosphate-buffered saline solution (PBS) for 15 
minutes at room temperature. Stained cells were then analyzed by flow cytometry 
using a FACScan cytometer and CellQuest software (Becton Dickinson). Red 
(FL2-H channel) fluorescence emissions from 104 cells were analyzed. 
 
 
 
 
Plaque Forming Assays 
 
 
Cells were plated overnight at varying densities in a 6-well plate.  The next 
day the cells were infected at the indicated PFU for 1 hour. The media was 
removed and the cells were washed.  10% SeaPaque agarose was mixed and 
melting with ddH2O. The agarose was diluted with culture media. Once the 
agarose had cooled to around 40°C it was added to the cells.  After the agarose 
cooled 1 ml of culture media was added to the cells.  Between days 5 and 7 the 
cells were stained with MTT and the diameter and quantity of the plaques was 
determined  using  the  UN-SCAN-IT  gel  version  6.1  software  (Silk  Scientists, 
Orem, UT). 
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Animal Experiments 
 
 
All animals were purchased through Jackson Laboratory and housed in 
the MD Anderson BSRB Animal Facility.  The GCN2 knockout mice (B6.129S6- 
Eif2ak4tm1.2Dron/J), originally generated by Dr. David Ron and were back 
crossed with C57BL/6J mice. C57BL/6J mice served as the wild-type strain. 
The animals were injected with Ad300, measured in virus particles/mouse, via tail 
vein injection.  Their weight was measured pre-injection and post-mortem.  The 
mice were monitored every day for moribundity.  If the mice appeared moribund 
then they were sacrificed and all of their organs were preserved. The tissues 
were processed and embedded through the MD Anderson Department of 
Veterinary Medicine. 
 
Immunofluorescence 
 
 
The organs were deparaffinized by baking the slides for 1 hour at 65°C. 
They were subsequently incubated in 3 washes of Xylene, 2 washes of 100% 
Ethanol, 2 washes in 95% Ethanol, and 1 wash in 70% Ethanol for 3 minutes 
each.  Then they were washed 3 times in PBS+ 0.05% Tween-20, and diH20 all 
for 5 minutes each.  The slides were then heated in prewarmed 10mM Sodium 
Citrate pH 6.0 for 30 minutes in a steamer.  The slides were allowed to cool for 
20 minutes on the bench top. Slides were then washed three times in PBS+ 
 
0.05% Tween-20 for 5 minutes.  The sections were marked using a hydrophobic 
pen and incubated overnight with the antibody and an IgG control with the same 
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amount of IgG from the 1° antibodies species. The next day the slides were 
washed 3 times with PBS+ 0.05% Tween-20 and incubated with the 2° antibody 
at a 1:400 dilution and incubated for 1 hour.  The slides were washed 3 times 
with PBS+ 0.05% Tween 20 for 5 minutes each.  The slides were counterstained 
with VECTASHIELD mounting medium with   Dapi (Vector Laboratories, 
Burlingame, CA). Images of the tissues were taken and processed on a Zeiss 
Axiovert Zoom fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY, USA) 
equipped with  AxioCam  MRM  camera  and  40x  1.3  oil  EC  Plan-NEOFLUAR 
objective, using Immersol (n = 1.518) at room temperature. Acquisition software 
was AxioVision Release 4.7.1 (Carl Zeiss, Inc.). 
 
 
 
 
 
Immunohistochemistry 
 
 
The organs were deparaffinized by baking the slides for 1 hour at 65°C. 
They were subsequently incubated in 3 washes of Xylene, 2 washes of 100% 
Ethanol, 2 washes in 95% Ethanol, and 1 wash in 70% Ethanol for 3 minutes 
each.  Then they were washed 3 times in PBS+ 0.05% Tween-20, and diH20 all 
for 5 minutes each.  The slides were then heated in prewarmed 100mM Sodium 
Citrate pH 6.0 for 30 minutes in a steamer.  The slides were allowed to cool for 
30 minutes on the bench top. Slides were then washed three times in PBS+ 
 
0.05% Tween-20. The sections were marked using a hydrophobic pen and 
incubated overnight with the antibody and an IgG control with the same amount 
of IgG from the 1° antibodies species.  The next day the slides were washed 3 
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times with PBS+ 0.05% Tween-20 and incubated with the 2° antibody at a 1:400 
dilution and incubated for 1 hour.  30 minutes before use the ABC reagent was 
prepared (Vector Laboratories). The slides were washed 3 times with PBS+ 
0.05% Tween 20.  The slides were incubated with the ABC reagent for one hour. 
Slides were washed 3 times with PBS+ 0.05% Tween-20. DAB+ H2O2 (Sigma 
Aldrich, St. Louis, MO) tablets were dissolved in tap water and added to the 
sections.  Once the slides were developed, they were washed 3 times in 3 with 
PBS+ 0.05% Tween-20.  Slides were dipped in Hematoxylin for 30 seconds and 
rinsed in water for five minutes.  Slides were incubated in 95% Ethanol, Xylene 3 
times each for 3 minutes and mounted with Permamount (Sigma Aldrich, St 
Louis, MO). Pictures were obtained through an Olympus BX41 with Olympus 
DP71 camera. 
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Chapter 3: Results 
 
 
 
Significance and Rationale 
 
Autophagy was discovered approximately forty years ago as a cellular 
response to starvation.  It has only recently been examined enough to join the 
ranks of apoptosis as an established form of programmed cell death.  In the past 
decade, many labs have focused on the relationship between viruses and 
autophagy. Autophagy investigation has become increasingly popular in 
laboratories studying pathogen infection and immunity (reviewed by (94)), but 
scientists have also examined how viruses manipulate the autophagy pathway to 
their advantage (reviewed by (95)). Our collaborator was the first to report that 
conditionally replicating adenoviruses induce autophagy (29), and, unfortunately, 
no group until ours has pursued any mechanistic studies. Therefore, it is 
imperative for the advancement of the area of adenovirus and autophagy that 
this is explored more in depth because understanding how adenovirus mediates 
autophagy is crucial translationally as a potential anticancer therapy, because of 
the  many  cancers  that  are  highly  resistant  to  conventional  pro-apoptotic 
therapies. 
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3.0 Examination of the Role Infection and Early Genes Play in Adenovirus 
 
Mediated Autophagy 
 
 
The role of replication during autophagy was carried out through 
experiments with adenovirus deleted of the E1 gene, rendering it incapable of 
replication.  U87.GFP-LC3  cells  were  generated  by  Dr.  Hong  Jiang  at  the 
University of Texas MD Anderson Cancer Center (MDACC). The GFP-LC3 
plasmid was originally constructed by Dr. Noboru Mizushima (96). U87.GFP- 
LC3 cells have a low basal level of autophagy, thus providing an optimum cell 
line for autophagic studies.  Autophagy is identified by punctate GFP staining of 
the cells versus diffuse cytoplasmic staining in the absence of autophagy.  The 
technique follows the movement of LC3-I to LC3-II incorporation into the 
autophagosome. U87.GFP-LC3 cells were infected with the AdOLE/1.8 virus 
(Delta-E1)  purchased  from  the  Keck  Memorial  Adenovirus  Core  at  MDACC 
(figure 3).  At increasing MOI, there was no increase in the GFP-LC3 punctate 
formation. Uninfected cells were used as a negative control and serum and 
glucose starved cells were the assay’s positive controls.  Delta-24-RGD infected 
cells served as a control for comparison between viruses. There was a 2.5 fold 
increase in GFP-LC3 punctuation in Delta-24-RGD infected cells over Delta-E1 
infected cells.  These results provide evidence that infection does not play a role 
in adenovirus-mediated autophagy. 
 
A second technique to confirm the role of infection on autophagy induction 
was to assay autophagy is through the accumulation of an acidotropic dye within 
the autophagosome.  Acridine orange emits red fluorescence when localized in 
27
 
 
an acidic compartment and fluoresces green when bound to DNA.  After infection 
with Delta-E1, there was no significant increase in the acidic apartments of the 
cell (figure 4).  Mock infection and serum and glucose starvation were used as 
assay positive controls.  Ad300 infection served as an infection control.  There 
was almost a 14-fold increase in acidic vacuoles in Ad300 infected cells over 
Delta-E1 infected cells.   Looking at the scattered population of cells, one sees 
that under glucose and serum free media starvation the population of cells 
increase in intracellular complexity. This can be contributed to the vacuolar 
structures now present in the cytoplasm.  Now examining wild-type infected cells 
the population increases in intracellular complexity but also in DNA content due 
to virus replication.  Acridine orange when bound to DNA fluoresces green and 
this is monitored through FL1-H.  During infection with a Delta-E1 virus there was 
no population shift in either direction, suggestion no increase in vacuoles or viral 
replication.  Infection does not increase acidic compartments in the cell. 
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Figure 3: A Replication-Deficient Virus Failed 
to  Induce  GFP-LC3  Punctata.  A)  U87-MG 
were stably transfected with a GFP-LC3 
construct.   Cells were visualized by 
fluorescence microscopy and cells with more 
than 5 GFP-LC3 punctata were considered 
positive for autophagy. Cells were incubated in 
complete media for 48 hours and infected with 
dl309 (an E1-deleted virus) at the multiplicity 
of  infection  (MOI)  indicated. Incubation  in 
 
serum and glucose media served as a positive control. B) GFP-LC3 positive 
cells were quantified.  Around 200 cells were counted per well and three wells 
were counted. 
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Figure 4:  A Replication-Deficient Virus Did Not Increase Lysosomal Vacuoles. A) 
Cells were treated as indicated.  48 hours after infected cells were incubated for 
15 minutes with Acridine Orange (1µg/ml). Cells were trypsinized and collected in 
PBS and analyzed by a Becton Dickson flow Cytometer. B) Quantification of 
acridine orange flow cytometry. 
 
Ultrastructure morphology  analysis  is  the  gold  standard  for  autophagy 
identification, therefore to confirm the previous experiments we infected MRC-5 
fibroblasts with Delta-E1 or wild-type adenovirus and compared the morphology 
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to  the  uninfected  control  (figure  5).  Cells  that  were  uninfected  displayed  a 
continuous cytoplasm sprinkled with mitochondria. The morphology for a cell 
infected with Delta-E1 looked remarkably similar.  There was no disruption in the 
cytoplasm. However,  cells  infected  with  wild-type  adenovirus  displayed  a 
strikingly different morphology. The cytoplasm was littered with vacuoles that 
appeared empty but upon amplification there are remnants of digested material 
inside of the vacuoles.  In the enlarged inset there are multi-lamellar structures 
inside of a vacuole to be digested. The nucleus has multiple virions present. 
Since there was no change in morphology we can interpret that infection does 
not play a role in autophagy induction. 
 
For biochemical confirmation, we analyzed the proteins p62 and LC3 for 
changes indicative to autophagy induction. p62 is a long-lived protein that is 
preferentially digested by autophagy (18).  Western blot analysis of the quantity 
of p62 within the cell is an indicator of autophagy. In accordance with our 
hypothesis, after infection with Delta-E1 there was no degradation of p62, and 
there was a decrease after infection with Delta-24-RGD (figure 6). A second 
biochemical marker of autophagy is the cleavage and subsequent lipidation of 
MAP-LC3b  (LC3). Under  basal  conditions  LC3  is  primarily  found  in  the 
uncleaved  state,  LC3-I. Monitoring  this  cleavage  from  LC3-I  to  LC3-II  is 
indicative of autophagy. Mock and Delta-E1 cells had a similar ratio of LC3- 
II/LC3-I. However,  upon  infection  with  Delta-24-RGD  all  of  the  LC3-I  was 
converted to LC3-II.  Therefore, with all of these results we can conclude that 
infection is not sufficient to induce autophagy. 
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Figure 5: Electron Micrographs Revealed No Ultrastructural Morphological 
Changes After Infection with Delta-E1. MRC-5 fetal lung fibroblasts were treated 
for 72 hours and then fixed and processed for electron microscopy. A) Mock 
Infected Cells, 6000x magnification. B) Delta-E1 infected at 100 MOI, 6000x 
magnification. C) Ad300 infected at 100 MOI, 6000x magnification. D) Ad300 
infected at 100 MOI, 25000x magnification. Dotted arrow: late stage 
autolysosome.  Solid arrow: autophagosome 
 
 
 
 
 
 
 
Figure 6: Only Replication Competent Viruses Induced Cleavage of LC3-I and 
Degradation of p62. MRC-5 fibroblasts were infected at 100 MOI for 72 hours. 
Cell were collected and subjected to western blotting.  A) p62 levels decreased 
after infection with a replication competent virus (Delta-24-RGD) and fail to 
decrease with the replication deficient virus.  LC3 was cleaved after infection with 
Delta-24-RGD and not after infected with Delta-E1.  B) Densitometry of LC3-I 
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Figure 7: Exogenous Expression of E1A Did Not Result in the Induction of 
Autophagy.  A) U87-MG cells were transfected with pCDNA3.1+ or pCDNA3.1- 
E1A 12S vectors for 48, 72, or 96 hours and analyzed for autophagy. B) 
Densitometry of the cleavage of LC3-I to LC3-II. 
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3.1 Overexpression of E1A Fails to Induce Autophagy 
 
 
We next asked whether E1A, the gene responsible for the replication 
deficiency in the Delta-E1 virus, was sufficient to induce autophagy when 
expressed alone.  Using a pCDNA3.1-12s E1A expression vector, U87 cells were 
transiently transfected and subsequently analyzed for autophagy via western 
blotting (figure 7). Comparing each time point to its own empty vector control 
there was no difference in the level of p62 despite strong E1A expression. 
Examination of LC3 in these same samples revealed no difference in the ratio of 
LC3-II/LC3-I. We can conclude that E1A is required for adenovirus-mediated 
autophagy, but not sufficient. 
 
 
 
 
 
3.2 Examining the Role of Adenoviral Early Genes on Autophagy Induction 
 
 
In order to isolate the function adenoviral early genes play in autophagy 
induction, we utilized viruses deleted for each early gene separately.  We were 
able to obtain knockout viruses for E1, E3, E1B55K, E4, and VARNA I&II.  We 
constructed the E1B19K deleted virus though the generation of stop codons in 
the open reading frame using site-directed mutagenesis (figure 8, top). The 
mutated sequence was confirmed through sequencing (figure 8, bottom). 
Secondly, we analyzed the virus for expression of E1B19K and E1B55K (figure 
9). We chose to amplify the mutant virus that had similar levels of E1B55K 
expression compared to wild type, while lacking expression of E1B19K.  Or first 
goal was to examine the capability of Delta-E1B19K to induce autophagy. Our 
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first comparative studies with Delta-E1B19K, were acridine orange staining after 
infection with Ad300 or Delta-E1B19K.  We showed that there were similar levels 
of AVO positive cells in a dose dependent manner (figure 10). These results 
indicate that E1B19K plays a partial role in adenovirus-mediated autophagy. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  8:  Schematic  Representing  the  Generation  of  an  E1B19K  Mutant 
 
Adenovirus. 
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Figure 9: Mutant Virus Failed to Express E1B19K, with No Effect on E1B55K.  A) 
293 serves as a positive control for E1B55K and E1B19K. U251-MG cells were 
mock infected, AdCMV (Delta-E1) infected, Ad300 (WT) infected, and E1B19K 
KO infected. 
 
 
 
 
 
Figure 10: Delta-E1B19K Increased the Volume of Acidic Compartments After 
Virus  Infection. A)  U251-MG  cells  were  infected  at  the  MOI  indicated  and 
analyzed for acridine orange staining 48 hours post infection. 
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Acridine orange examination of Delta-E1B19K revealed there was not a 
complete abolishment of autophagy. We chose to examine this phenomenon 
more in depth. E1B19K is known to interact with E1B19K interacting Protein 
(Bnip3) through a BH-like domain.  Bcl-2 encompasses a BH3 domain that binds 
to  Beclin  1  to  inhibit  autophagy. E1B19K  is  a  homologue  of  BCL-2. We 
proposed that E1B19K interacted with Beclin 1 to regulate autophagy.  The first 
experiment was immunoprecipitation of E1B19K and examination of Beclin 1. 
Infection of HeLa cells with Delta-24-RGD or Delta-E1B19K and subsequent co- 
immunoprecipitation revealed that only an E1B19K expressing adenovirus could 
co-immunoprecipitate Beclin  1  (figure  11). The  converse  experiment  pulling 
down Beclin 1 could still precipitate E1B19K. Therefore, we concluded that 
E1B19K does, in fact, bind to Beclin 1 in vitro. 
 
It is relevant to also establish the Beclin 1 binds to PI3K CIII. Beclin 1 
must associate with PI3K CIII in order to induce autophagy. A time course 
experiment revealed that PI3KCIII associated in a complex with E1B19K and 
Beclin 1 while BCL2 did not (figure 12). Beginning at 6 hours post infection 
PI3KCIII was detected with co-immunoprecipitation with Beclin 1 while BCL2 
detection in the complex decreased. Simultaneously, immunoprecipitation with 
E1B19K revealed that PI3KCIII co-immunoprecipitated with increased time while 
BCL2 was never detected.  We discovered that E1B19K competes with Bcl-2 to 
bind Beclin 1 and that Beclin 1, E1B19K, and E1B19K all exist in a complex 
together. 
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We noticed through gross microscopic analysis of the cells revealed that 
at 48 hours 100% of the cells were floating and revealing cytopathic effect.  We 
chose to look at the induction of apoptosis because earlier studies revealed there 
was  not  an  increase  in  autophagy  induction. Infection  with  Delta-E1B19K 
revealed an increase in cleaved PARP while only in the presence of E1B19K 
PARP  remained  in  the  uncleaved  form  (figure  13). Therefore,  deletion  of 
E1B19K fails to induce autophagy, which subsequently leads the cells to undergo 
apoptosis. 
 
Since there was an increase in apoptosis, we sought to establish whether 
the replication cycles of these to virus were similar. HeLa cells were infected 
with Ad300, Delta-E1B19K and Delta-24-RGD (figure 14). 48 hours later the 
cells and supernatant were collected and analyzed for infectious viral progeny. 
Delta-E1B19K had a 70% and 64% decrease in replication compared with Ad300 
(student’s t-test p=0.0004) and Delta-24-RGD respectively. Deletion of E1B19K 
causes the cells to undergo apoptosis causing the cells to die before a full 
replication cycle has concluded. 
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Figure 11: E1B19K Binds to Beclin 1 in vivo.  Infection with of HeLa cells with 
Delta-24-RGD or Delta-E1B19K and subsequent co-immunoprecipitation reveals 
that only an E1B19K expressing adenovirus can co-immunoprecipitate Beclin 1. 
The converse experiment pulling down Beclin 1 can still precipitate E1B19K. 
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Figure 12: A Time Course Experiment Revealed that PI3KCIII Associates in a 
Complex with E1B19K and Beclin 1 while BCL2 Does Not.  Beginning at 6 hours 
post infection  PI3KCIII was detected with immunoprecipitation with Beclin 1 
while BCL2 detection in the complex decreased. Simultaneously, 
immunoprecipitation with E1B19K revealed that PI3KCIII co-immunoprecipitated 
with increased time while BCL2 was never detected. 
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Figure 13: Infection With Delta-E1B19K Led to Increased Cleavage of PARP. 
Cells were infected with each virus and assayed by Immunoblotting for PARP 
cleavage. 
 
 
 
 
 
Figure  14:  Delta-24-RGD  Revealed  Impaired  Replication. HeLa  cells  were 
infected with Ad300, Delta-E1B19K and Delta-24-RGD.  48 hours later the cells 
and supernatant were collected and analyzed for infectious viral progeny. 
p=0.0004. 
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We  examined  the  ability  of  all  of  our  knockout  viruses  to  induce 
autophagy.  Ultrastructure morphology studies revealed similar results as earlier 
stated.  The Delta-E1 infected control cell displayed a continuous cytoplasm with 
mitochondria and ER clearly present. The cell infected with Delta-24-RGD 
adenovirus has a disrupted cytoplasm with autophagic vacuoles.  Item D shows a 
phagosome with multi-lamellar structure present and also vacuoles with digested 
material inside.  The nucleus was spotted with virions. Infection with Delta-E3, 
Delta-E1B19K, Delta-E4, and Delta-VARNA all exhibited a similar phenotype 
(figure 15:A-L). None of the genes were required for adenovirus mediated 
autophagy. 
 
It was also important that we examined LC3 punctuation after infection 
with the mutants for biochemical confirmation.  Cells with more than five GFP- 
LC3  dots  were  considered  positive  for  autophagy. Replication  competent 
mutants had a 3-7 fold increase in the number of autophagy positive cells over 
the  mock treated and  Delta-E1treated  controls  (figure  16). This  experiment 
indicated that no single viral gene tested, except E1A, is required for adenovirus- 
mediated autophagy. 
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Figure 15: Ultrastructure Studies of MRC-5 Infected with Adenovirus Mutants 
Revealed the Presence of Autophagosomes. A) Delta-E1 virus 100 MOI, 5000x 
magnification. B) Delta-E1 virus 100 MOI, 25000x, magnification. C) Delta-E3 
virus (Delta-24-DGD) 100 MOI, 6000x magnification.  D) Delta-E3 virus (Delta- 
24-DGD) 100 MOI, 25000x, magnification. E) Delta-E3 virus (Ad300) 100 MOI, 
 
6000x magnification.  F) Delta-E3 virus (Ad300) 100 MOI, 25000x, magnification. 
G) Delta-E1B19K virus 100 MOI, 6000x magnification. H) Delta-E1B19K virus 
100 MOI, 25000x, magnification. I) Delta-E4 virus (dl366) 100 MOI, 6000x 
magnification. J) Delta-E4 virus (dl366) 100 MOI, 25000x, magnification. K) 
Delta-VARNA virus 100 MOI, 6000x magnification. L) Delta-VARNA virus 100 
MOI,  25000x,  magnification. Dotted  arrow:  late  stage  autolysosome. Solid 
arrow: autophagosome 
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Figure 16: All Mutant Viruses, Induced GFP-LC3 Punctate Staining. U87-MG 
 
cells stably transfected with GFP-LC3 and either mock infected or infected with 
adenovirus mutants at 30 MOI.  Cells with greater than five GFP-LC3 punctata 
were considered positive for autophagy.   A) 1.Mock infection.  2. Delta-E1.  3. 
Delta-24-RGD.  4. Delta-E3. 5. Delta-E1B55K.  6. Delta-E1B19K.  7. Delta-E4. 8. 
Delta-VARNA-I. B) Quantitation of the wells. 
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4.0 Intracellular ATP levels decrease after adenovirus infection 
 
 
Jiang et. al. 2008 proposed that a possible mechanism of adenovirus- 
mediated autophagy was that the virus induces a hyperanabolic state.  Increased 
energy demands for the production of the virus can stress the cell and deplete 
ATP stores. We wanted to measure the intracellular levels of ATP after virus 
infection and we were able to accomplish this by utilizing an Intracellular 
bioluminescence kit that needs ATP to facilitate the reaction of D-luciferin and O2 
to produce light.  We infected U251 cells at 100 MOI for 24-72 hours (figure 17). 
We collected the cells by lysing them in water and used an aliquot as the ATP 
source  for  our  bioluminescent  reaction. At  24  hours  there  was  a  2.6  fold 
decrease in ATP levels.  That difference increased to 4 and 5 fold at 48 and 72 
hours respectively. Therefore, there is a decrease in ATP which could be a 
trigger for autophagy induction. 
 
4.1 Intracellular sensors for ATP as effectors of autophagy induction 
 
 
LKB1  is  the  kinase  that  regulates  AMPK. AMPK  is  the  sensor  for 
intracellular ATP. In order to study the role that LKB1 and AMPK play in the 
induction of adenovirus mediated autophagy we obtained shLKB1 U251 cells and 
AMPKα1α2 null MEFs from our collaborators.  U251 cells were transfected with 
shRNA against LKB1 and clones were picked to analyze the expression level. 
We  chose  the  clone  with  the  least  amount  of  expression  and  infected  the 
parental, shControl, and shLKB1 cell lines with 30 MOI of Ad300 (figure 18). 
Infection  of  shLKB1  had  no  bearing  on  the  ability  of  adenovirus  to  induce 
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autophagy.  We analyzed acidic vacuoles and LC-3 cleavage and there was no 
difference between the parental cell lines, control cells lines or the 
knockout/knockdown cell lines. Infection with AMPKα1α2 null MEFs revealed 
similar findings (figure 19 and 20).  This data indicate that LKB1, and AMPK do 
not play a role in adenovirus-mediated autophagy. 
 
 
 
 
 
 
 
 
 
Figure 17: Infection with Ad300 Decreased the Levels of Intracellular ATP. 
U251 cells were plated in triplicate and infected with Ad300 at 100 MOI.  Every 
24 hours the cells were collected, lysed in diH2O and analyzed using an ATP 
 
intracellular bioluminescence assay.  ANOVA p< 0.0001. 
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Figure 18: shLKB1 Knockdown Cells Revealed No Difference in Acridine Orange 
Staining Compared to Wild-type Cells.  A) U251-MG, shCont and shLKB1 cells 
were infected at 30 MOI and analyzed for acridine orange staining 48 hours post 
infection. 
 
 
 
 
 
 
 
 
 
Figure 19: AMPKα1α2 Null MEFs Revealed No Difference in Acridine Orange 
Staining  Compared  to  Wild-type  Cells. Underwent  Autophagy  After  Virus 
Infection.  A) AMPK wild-type and AMPKα1α2 null MEFs were infected at 50 MOI 
and analyzed for acridine orange staining 48 hours post infection. 
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Figure 20: AMPKα1α2 Knockout Cells 
 
Underwent Autophagy After Virus Infection.  A) AMPK wild-type and AMPKα1α2 
knockout cells were infected at 50 MOI and analyzed for LC3 cleavage 48 hours 
post infection. B) Densitometric analysis of LC-3 cleavage. 
 
 
 
 
 
 
4.2 Adenovirus activates the AKT pathway during late stage viral infection 
 
 
The current model of starvation-mediated autophagy implies a decrease in 
the activity level of the AKT/mTOR pathway.  Using an antibody array, we found 
that AKT was phosphorylated in response to adenovirus infection at residue 
S473 16 hours after infection and at residue T308 36 hours after infection (Figure 
21).  AKT must be phosphorylated at both residues to be maximally active (97). 
This indicates that it was only active during the late stage of viral infection, 36 
hours. Interestingly levels of phosphorylation on residue S2448 of mTOR were, 
in most part, unchanged until the late stage of viral infection.  Interestingly, one of 
the most prevalent mTOR targets, p70S6K, was phosphorylated at its active site, 
T398 despite little or no changes of mTOR phosphorylation at 16 hours. AKT 
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and mTOR are activated during late hours of infection and therefore we looked 
further into the pathway. 
 
4.3 Downregulation of TSC2 fails to prevent adenovirus-mediated 
autophagy. 
 
To further dissect the role of the AKT/AMPK/mTOR pathway, we obtained 
TSC2 knockdown cells to examine the role TSC2 played in the induction of 
autophagy after adenovirus infection.  U251 cells were transfected with shRNA 
against TSC2 and clones were picked to analyze the expression level. We 
chose the clone with the least amount of expression and infected the parental, 
shControl, and shTSC2 cell lines with 30 MOI of Ad300 (figure 22).  There was 
no change in the volume of acidic compartments or the number of cells that were 
positive  for  acidic  compartments. We  also  analyzed  LC-3  cleavage  as  an 
indicator of autophagy and found there was no difference between any of the cell 
lines (figure 23).  TSC2 does not play a role in adenovirus mediated autophagy 
therefore, there with the array data and the lack of involvement of TSC2, we 
cannot conclude that the AKT/mTOR pathway play a role in adenovirus-mediated 
autophagy. 
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Figure 21: Activation of the AKT Pathway After Adenovirus Infection.  A) MRC-5 
cells were infected at 100 MOI and collect at 16, 32, and 48 hours.  The lysates 
were subjected to an AKT antibody array from R&D Systems. 
 
 
 
 
 
Figure 22: shTSC2 Knockout Cells Revealed No Difference in Acridine Orange 
Staining Compared to Wild-type.  A) Generation of TSC2 shRNA downregulated 
cell line. B) U251 parental, shCont, or shTSC2 cells were infected at 30 MOI and 
analyzed for acridine orange staining 48 hours post infection. 
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Figure 23: shTSC2 Cells Undergo Autophagy After Virus Infection. A) TSC2 
wild-type and TSC2 downregulated cells were infected at 30 MOI and analyzed 
for LC3 cleavage 48 hours post infection. 
 
 
 
 
 
4.4 eIF2α Phosphorylation Increases After Viral Infection 
 
 
Other   pathways besides the AKT pathway are known to induce 
autophagy. For instance, PKR is known to phosphorylate eIF2α during viral 
infections  (55). Thus,  we  monitored  eIF2α  phosphorylation  levels  during 
adenoviral infection, in our study.  MRC-5 cells were infected at 100 MOI, and 
eIF2α phosphorylation was monitored every 12 hours.  Figure  24 demonstrates 
that eIF2α phosphorylation increased starting 36 hours after infection and 
culminated with a 3-fold total increase at 48 hours, with no change in the total 
levels of eIF2α. There was also an inverse correlation with the levels of eIF2α 
phosphorylation and the decrease in the levels of p62, suggesting that eIF2α 
may be involved in autophagy induction. 
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4.5 Examination of PERK 
 
 
There are four kinases that are responsible for eIF2α phosphorylation.  Of 
those four, we chose to examine PERK and GCN2.  PERK activation is primarily 
monitored by investigating its downstream effectors.  PERK increases translation 
of chaperone proteins during ER stress.  We infected U251 cells at 100MOI and 
examined disulfide isomerase (PDI) and BiP (figure 25).  Unexpectedly, we saw 
a disappearance of these proteins after virus infection despite an increase in 
eIF2α phosphorylation. 
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Figure 24: Translation  Initiation Factor eIF2α  is  Phosphorylated During 
Adenovirus Infection. U251-MG cells were infected at 100 MOI and the cell 
lysates  were analyzed   by western blotting for autophagy and  eIF2α 
phosphorylation status. A) eIF2α is phosphorylated between 24 and 48 hours 
after virus infection without changes in the total levels of eIF2α.  This degradation 
also correlates with a dramatic p62 degradation.  B) Densitometry of phospho- 
eIF2α/total eIF2α and normalized to actin.  C) Densitometry of p62 normalized to 
actin. 
 
 
 
 
 
Figure 25: ER Stress Proteins are Degraded During Virus Infection. A) U251 
 
Cells were infected and cell lysates were collected at the time points indicated. 
PDI and BiP (chaperone proteins) were degraded after virus infection despite 
eIF2α phosphorylation. 
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4.6 Examination of GCN2 
 
 
Next, we obtained GCN2 knockout mouse embryonic fibroblasts to study 
the role of GCN2 in the induction of autophagy.  Upon infection it was abundantly 
clear that these cells were highly resistant to the cytopathic effect of the virus 
(figure  26). Trypan  blue  viability  studies  confirmed  the  observation. Mock 
treated cells were 94% and 96% viable for wild-type and knockout cell lines, 
respectively  (figure  27).  Similar  levels  of  viability  were  seen  with  Delta-E1 
infected cells with 91 and 94% viability, respectively.  However, at 50 MOI and 
100 MOI viability dropped 64% and 70% for wild-type cells, respectively. The 
 
GCN2 knockout cells had relatively no change in viability 50 and 100 MOI yielded 
 
90 and 92% viability, respectively ( student’s t-test p=0.0001).  A second method 
was used to examine viability of the cells, crystal violet.  Cells were seeded in a 
12-well plate and infected at increasing MOI (figure 28).  96 hours later cells were 
stained with the dye crystal violet.  Most of the wild-type cells were completely 
cytopathic  and lifted off of the plate at 50 MOI.  This supports the lack of change 
in the trypan blue viability data at 50 and 100 MOI for wild-type cells.  However, 
the  amount of crystal violet  retained  by  GCN2  knockout  cells  remains  fairly 
constant, with only a slight decrease in crystal violet retention at 160 MOI.  We 
repeated the experiment with an MOI up to 300 and we still continued to see a 
resistance of GCN2 knockout cells to adenovirus induced cytopathic effect (figure 
29).  We concluded that GCN2 was involved in the cellular response to the virus 
and decided to examine autophagy induction. 
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In order to examine autophagy in the GCN2 null cells, we used acridine 
orange, an acidotropic dye, to quantify the acidic vacuoles in the cell.  The cells 
were infected at 50 MOI and analyzed with acridine orange 72 hours later (figure 
30).  There was a 3-fold increase in the percent cells positive for acidic vacuoles 
over the GCN2 null cells.  This data implies that the GCN2 cells are impaired for 
autophagy induction after adenovirus infection. 
 
For further conformation on the presence of autophagy we analyzed the 
cells for LC3 cleavage.  Both cell lines were infected at 50 MOI and analyzed 48 
hours post infection (figure 31).  LC3-I was completely cleaved into LC3-II and 
that autophagosome completely degraded LC3-II, where it was not visible via 
western blotting. On the other hand, there was only slight cleavage of LC3-I to 
LC3-II in the GCN2 knockout cells.   GCN2 cells do not undergo autophagy. 
 
To confirm our biochemical data we analyzed the cells for autophagy 
through the gold standard for visualization of autophagy, which is electron 
microscopy.  Both cell lines were infected with the same multiplicity of infection 
and fixed 72 hours post infection.  Wild-type cells displayed a similar morphology 
to human cells infected with virus (figure 32b).  The only difference was the lack 
of virions present in the cell due to the semi-permissive replication status of 
murine cells. This was expected as these cells are only semi-permissive to 
adenovirus replication.  However, the GCN2 knockout cells appeared extremely 
similar to the untreated control cells (32a and d).  There was no rounding of the 
cell and no gross vacuolar structures in the cytoplasm.  We concluded GCN2 null 
cells do not undergo autophagy like their wild-type counterparts. 
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Figure 26:  GCN2 Null Mefs are Resistant to Virus Infection.  A) Wild-type and 
knockout MEFS were seeded at 5x105 cells per well.  Cells were infected at 50 
MOI and visualized by phase contrast microscopy 72 hours post infection. 
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Figure 27: GCN2 Knockout MEFs Have Increased Viability After Adenovirus 
Infection. 4x104  cells were seeded in a 12-well plate infected at the indicated 
MOIs. Floating cells were collected and the remaining cells were rinsed with 
PBS, trypsinized and combined with the floating cells and analyzed on an 
automated cell counter. 
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Figure  28:  Loss  of  GCN2  Renders  Cells  Resistant  to  Adenovirus  Infection. 
 
8.0x104 cells were seeded in a 24 well plate and infected with adenovirus as 
indicated.  96 hours later the media was aspirated, cells were washed with PBS, 
and stained with 0.05% Crystal Violet in 20% methanol for 10 minutes. Cells 
were washed and crystal violet was solubilized with 1% SDS and read at a 
wavelength of 570nm in a spectrophotometer.  Two way ANOVA, p<0.0001. 
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Figure 29: Even at High Mulitiplicities of Infection, GCN2 KO Cells are Resistant 
to Virus Infection. 8.0x104 cells were seeded in a 24 well plate and infected with 
adenovirus as indicated. 96 hours later the media was aspirated, cells were 
washed with PBS, and stained with 0.05% Crystal Violet in 20% methanol for 10 
minutes.  Cells were washed and crystal violet was solubilized with 1% SDS and 
read at a wavelength of 570nm in a spectrophotometer. Two way ANOVA, 
p<0.0001. 
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Figure 30:  GCN2 Knockout MEFs Have Decreased Levels of Autophagy After 
Infection.  A) 2x105 cells were seeded per well in a six-well plate and treated as 
indicated.  Cells were analyzed 48 hours post infection. Students t-test, p<0.001 
 
 
 
 
 
 
 
 
 
Figure 31: GCN2 Null MEFs Failed to Cleave LC3 or Degrade p62 After Virus 
 
Infection. 1x106  GCN2 Wild-type and GCN2 Knockout MEFs were seeded in a 
 
10cm dish and infected at 50 MOI.  Cells were harvested 72 hours post infection 
and subjected to immunoblotting. 
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Figure 32: Ultrastructure Analysis Revealed a Lack of Autophagosome Induction 
After Virus Infection in GCN2 Knockout MEFs.  A) GCN2 Wild-type MEFs, mock 
infected, 4000x Magnification.  B) GCN2 Wild-type MEFs, Ad300 infected, 4000x 
Magnification. C) GCN2 Knockout MEFs, mock infected, 4000x Magnification. 
D) GCN2 Knockout MEFs, Ad300 infected, 4000x Magnification. Solid arrow: 
autolysosome. 
 
 
 
 
 
4.7 In vivo analysis of GCN2 
 
 
It  was  important  to  not  only  understand  the  implications  of  GCN2 
deficiency in vitro but we also wanted to analyze the role of GCN2 in vivo.  We 
infected wild-type and GCN2 knockout mice with adenovirus and analyzed the 
difference in liver morphology and cytotoxicity.  Adenovirus has a strong tropism 
for  the  liver  and  therefore  is  the  most  appropriate  organ  to  examine  for 
adenovirus toxicity.  We found that the knockout mice had a strikingly different 
morphology compared to wild-type mice. The knockout mice had twice the 
amount of necrosis compared to wild-type mice.  At high doses of viral infection 
which kill the mice in 3 days, wild-type pathology revealed acute coagulation 
periportal necrosis (figure 33A).  However, in the knockout mice the necrosis was 
not confined solely to the periportal region anymore (figure 33B).  The necrosis 
was diffused throughout the liver.  The knockout mice also had hemorrhage in 
their liver. At three days there was no evidence of infiltration and the Kupffer 
cells were still inactive. This was probably due to the insufficient time for the 
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immune  system  to  react. We  were,  however,  able  to  detect  E1A  via 
immunohistochemistry in both of these livers (figure 34A and B).  Therefore we 
can conclude that the E1A was responsible for the cell death in these livers. 
Mice that were infected with 5x109 vp/mouse and euthanized on day 7 revealed a 
less severe pathology. Both groups had necrosis and the knockout mice had 
twice the amount of necrosis versus the wild-type group (figure 35 a) (student’s t- 
test p<0.05). An interesting finding was that E1A expression seemed to be 
congruent with cell death (figure 35b).  The knockout mouse livers had twice the 
amount of cell death and half the amount of E1A.  At day 7, one can visualize the 
increased lymphocytic infiltration and Kupffer cell hyperplasia, although there 
was increased Kupffer cell hyperplasia in the knockout mice. Interestingly the 
knockout mice also had depletion of their bone marrow as revealed by 
microscopic analysis of their femur and sternum. In order to characterize 
autophagy in these animals we performed immunofluorescence for the 
autophagy  protein  p62  (figure  36).  p62  punctuation  in  the  cytoplasm  was 
revealed in wild-type mice infected with adenovirus while the GCN2 knockout 
mice infected with virus did not have p62 foci in the cytoplasm; nor did the PBS 
controls.  Therefore, we can conclude that the GCN2 null mouse livers in vivo do 
not undergo autophagy, similarly to the GCN2 null cells in vitro. 
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Figure 33: GCN2 Null Mice Undergo Large Amounts of Necrosis and 
Hemorrhage After Infection with Extremely High Viral Doses. GCN2 wild-type (A) 
and knockout mice (B) were injected with 1x1011 vp/mouse via tail vein injection. 
The mice were euthanized 3 days later. Solid arrow: necrosis. Dashed arrow: 
hemorrhage. 
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Figure 34: GCN2 Wild-type and Null Mice Both Express E1A.  GCN2 wild-type 
(A) and knockout mice (B) were injected with 1x1011  vp/mouse via tail vein 
injection.  The mice were euthanized 3 days later.  Their livers were extracted, 
embedded in paraffin, and subjected to E1A immunohistochemistry. 
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Figure 35: Cell Death in Mouse Livers is Congruent with E1A Expression.  Mice 
were infected with 5x109 virus particles per mouse and analyzed for E1A and cell 
death. 
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Figure 36: Autophagic Analysis of Livers from GCN2 Wild-type and Knockout 
Mice.   Mice were infected with 5x109  virus particles per mouse or PBS via tail 
vein injection.  Mice were euthanized and their livers were fixed in formalin and 
analyzed for the autophagy protein p62. 
 
 
 
 
 
5.0 Examination of Cell Lysis after Adenovirus Infection 
 
 
To first examine the correlation between adenovirus replication and 
autophagy we treated cells with the late stage autophagy inhibitor Bafilomycin A1 
(figure 37).  The control cells had a continuous cytoplasm with no disturbances. 
Treatment with Bafilomycin  alone  did  halt  the  basal  autophagy  process  and 
vacuoles with undigested material were detected. Treatment with adenovirus 
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was  visually  drastically  different  than  with  Bafilomycin  alone. Most  of  the 
vacuoles appeared white or empty and some had some remnants of digested 
cytoplasmic  material. However,  treatment  with  Bafilomycin  and  adenovirus 
revealed a substantial increase in the number of vacuoles suggesting a decrease 
in the turnover of vacuoles.  The vacuoles were filled with undigested material. 
Treatment with Bafilomycin A1 did not increase cell lysis and viral particles were 
visible in the nucleus (figure 37).  We wanted to analyze whether the inhibition of 
autophagy had any effect on replication and we confirmed that replication was 
still occurring though a replication assay (figure 38). There was no statistical 
significant difference between untreated and Bafilomycin treated cells. 
 
We believed that lysis may be a late event in viral replication. Therefore, 
we decided to visualize the process of lysis during adenovirus infected through 
time point experiments chronicling every 12 hours of virus infection from 0 hours 
to 120 hours (figure 39). We infected U251 cells with 100 MOI of wild-type 
adenovirus.  Figure 39 shows 0 hours, 72 hours, 96 hours, and 108 hours.  At 72 
hours the membranes remained intact.  There was a large quantity of virus in the 
nucleus and large vacuoles in the cytoplasm. However, there was still strong 
staining by osmium tetroxide.  It was not until 96 hours when it was possible to 
see active breakage of the membrane.  The cytoplasm was being degraded as 
evidenced by lack of osmium tetroxide staining.  At 108 hours the nucleus and 
cytoplasm were completely degraded. The cells had no membrane integrity. 
The inset shows where the outer membrane was broken and released contents 
into  the  media. We  can  derive  from  this  experiment  that  autophagy  does 
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participate in degradation of the cytoplasm and membrane the can aid in cell 
lysis. 
 
5.1 Autophagy induces and inhibitors regulate the viral plaque area 
 
 
One assay to asses viral spread and lysis is through a plaque forming 
assay.  The media is replaced by agarose so the virions cannot passively move 
and infect the neighboring cells. We first examined, the autophagy inducer, 
rapamycin on its ability to increase viral lysis.  We showed that there was a dose 
dependent increase in the total area of plaques (figure 40). From virus alone to 
virus plus 300nM of rapamycin there was a 1.88 fold increase in the area of 
plaques. 300nM to 500nM increase in rapamycin concentration increased the 
area of plaques by 1.38 folds.  Therefore comparing 500nM rapamycin to virus 
alone there was an increase of 2.6 folds.  We saw a slight increase in the number 
of plaques and wanted to further examine the effect on replication with hexon 
staining assays.  U251 cells were infected at 30 MOI with wild-type adenovirus 
and the cells and supernatant were collected and examined for the presence of 
infectious  virions  (figure  41). There  was  a  significant  increase  in  the  titer 
between  virus  alone  and  virus  plus  rapamycin  (p=0.0052). Therefore,  we 
conclude that rapamycin does aid in viral lysis and increases replication. 
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Figure 37: Bafilomycin Inhibits Autophagosomal Degradation During Adenovirus 
Infection.  MRC5 cells were either mock infected (A),  treated  150µM Bafilomycin 
A1 (B), infected at 100 MOI with Ad300 (C), or treated with 150µM Bafilomycin 
A1 and infected with Ad300 (D). Solid arrow: autophagosome. Dashed arrow: 
autolysosome. 
 
 
 
 
 
 
 
 
Figure 38: Treatment with Bafilomycin A1 Does Not Have an Effect on Viral 
Replication.  MRC5 cells were treated with DMSO or Bafilomcyin A1 at 150µM. 
They were infected at 100 MOI with Ad300.  After 72 hours the supernatant and 
the cells were collected and subjected two 3 freeze thaw cycles. The virus 
containing media was used for a hexon staining replication assay. 
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Figure 39: U251 Cells Infected with Ad300 Display Increased Membrane 
Degradation Over Time.   1x106  U251 cells were plated in a 10cm dish and 
infected with 100 MOI. Cells were collected at the time point indicated and 
analyzed for cell lysis A) 0 hours B) 72 hours C) Inset of 72 hours.  Long arrow 
indicates viral inclusion.  White arrow shows double membrane. Small arrow 
indicated virus particle. D) 96 hours E) 108 Hours. Long arrow indicates 
membrane breakage. F) Inset of 108 hours. Small arrow indicates virus particle. 
Long arrow indicates membrane breakage. 
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Figure 40: Rapamycin Increased the Number of Plaques and the Size. Cells 
were plated, infected as indicated, overlaid with agarose, and treated with 
Rapamycin as indicated.  7 days later the cells were stained with MTT and lysis 
was quantified. 
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Figure 41: Rapamycin Increased Viral Titer.  U251 cells were treated with DMSO 
or Rapamycin at 300nM.  They were infected at 100 MOI with Ad300.  After 96 
hours the supernatant and the cells were collected and subjected two 3 freeze 
thaw  cycles. The  virus  containing  media  was  used  for  a  hexon  staining 
replication assay. p=0.0052 
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We also wanted to further study the phenomenon of increased viral lysis 
with   autophagy  inducers   and   thus   we   chose   2-deoxyglucose   (98). 2- 
deoxyglucose is a glucose analog that cannot be broken down and halts 
glycolysis (99).  Treatment of U2-OS cells with virus alone at 200 and 400 PFU 
did not increase the total area of pixels (figure 41).  There was a 2.9 fold increase 
in the total pixel area with 800 PFU.  Looking at the same PFU but with treatment 
and without treatment with 2-DG showed a 1.28, 5.78, and 3.18 fold increase for 
200, 400 and 800 PFU, respectively. The autophagy inducer 2-DG, similar to 
rapamycin, increases cell lysis. 
 
Conversely, experiments with an autophagy inhibitor, 3-MA were 
undertaken to examine the effect of autophagy impairment on cell lysis. Cells 
were treated with 1mM and 3mM 3-MA and infected at 150 PFU (figure 42). 
There was a decrease in the total number of plaques after 3-MA treatment and 
there was also 3-fold decrease in the total read of plaques, however not in a 
dose  dependent  manner. Therefore,  we  can  conclude  that  inhibition  of 
autophagy with 3-MA decreases viral spread. 
 
5.2 3-MA decreases cell lysis 
 
 
As a more direct assay for examining lysis, we used a dye, ethidium 
homodimer-1 that only stains dead (permeable) cells.  We used 3-MA to inhibit 
autophagy during virus infection.  As proof of principle, we stained the cells with 
acridine orange and there was a significant decrease in AVO positive cells after 
treatment  with  3-MA  (student’s  t-test  p=0.001)  and  there  was  a  significant 
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increase in AVO positive cells after virus treatment with water as a control 
(student’s t-test p=0.005) (figure 44a).  To examine the lysed cells we sorted the 
cells along with x-axis with forward scatter and along with y-axis with log FL-3. 
Treatment with the virus and water as a control led to a 25% increase in lysed 
cells (student’s t-test p=0.001), while treatment with virus and 3-MA leads to less 
than a 15% increase in lysed cells (student’s t-test p=0.003) (figure 44b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42: 2-Deoxyglucose Increased the Number of Plaques and the Size of 
Plaques. Cells were plated, infected as indicated, overlaid with agarose, and 
treated with 2-DG as indicated.  7 days later the cells were stained with MTT and 
lysis was quantified. 
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Figure 43: 3-Methyladenine Decreased Plaque Number and Overall Plaque Size. 
Cells were plated, infected as indicated, overlaid with agarose, and treated with 
3-MA as indicated.  7 days later the cells were stained with MTT and lysis was 
quantified. 
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Figure 44. 3-MA Inhibits AVO formation and Cell Lysis.  U-87 cells were treated 
with 3-MA and adenovirus an analyzed for AVO formation and cell lysis using 
ethidium homodimer 1. 
 
5.3 Knockdown or downmodulation of ATG5 impairs cell lysis 
 
 
We also used a cell biology approach to inhibit autophagy versus using 
chemical inhibition.  Atg5 knockout mouse embryonic fibroblasts were a gift from 
Dr. Seiji Kondo (100). In order to understand the role autophagy plays during 
lysis we utilized autophagy-deficient ATG5 knockout MEFs to study lysis during 
viral infection.  The first experiment was to study the morphological changes after 
virus infection. Electron microscopy revealed a complete difference in 
morphology  between  the  wild-type  and  knockout  cell  lines  (figure  45). The 
morphology  was  similar  to  the  GCN2  deficient  cells  after  infection  with 
adenovirus. There  was  no   rounding  of  the  cells,  no  accumulation  of 
autophagosomes or degradation of the cytoplasm in knockout cells compared to 
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wild-type cells. Cytoplasmic whorls were present in the wild-type infected cell 
line.  We concluded that Atg5 null cells do not display a phenotype corresponding 
to autophagy after adenovirus infection.  We decided to study this further using 
lysis assays. 
 
Infection of wild type and ATG5 deficient cells led to a drastically different 
phenotype.  Infection with the virus in autophagy deficient cells does not cause 
cytopathic effect.  In a dose dependent experiment infection with 20, 50 and 100 
MOI leads to a complete conversion of LC3-I to LC3-II at 100 MOI and no 
conversion at all in the ATG5 knockout MEFs (figure 46).  Interestingly there is 
differential  expression  in  fiber  between  the  two  cell  lines. Fiber  starts  to 
accumulate at 20 MOI and it does not start to appear in the wild-type cells until 
50 MOI.  Wild-type mouse cells undergo autophagy and cells deficient for ATG5 
do not undergo autophagy. 
 
Next we examined the difference between cell lysis in these to cell lines. 
Application of ethidium homodimer-1 to the cells revealed a 3.5% cell death with 
mock, and 10.2, 37.9 and 69.8 for 20, 50 and 100 MOI respectively (figure 47). 
While in the ATG5 deficient cell lines the amount of cell lysis was 1.9, 2.6, 5.0 
and 9.1 for mock, 20, 50, and 100 MOI respectively.  While there was a slight 
increase in the number of lysed cells there was still a 7.7 fold increase in the 
number of lysed cells after 100 MOI between the two cell lines.  This experiment 
showed that autophagy is important for cell lysis. 
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When we analyzed replication we found there was no difference between 
Bafilomycin A1 treated cells and vehicle treated cells.  We opted to downregulate 
the  autophagy  protein  ATG5  to  inhibit  autophagy  (figure  48). We  stably 
transfected U87 cells with shRNA against ATG5 and selected the two clones with 
the largest decrease of ATG5 and least functional autophagy pathway.  Western 
blot analysis confirmed the decrease in ATG5 expression and we used 2 clones, 
#2 and #11 for our experiments.  Upon infection of the cells with 10 MOI Delta- 
 
24-RGD for 72 hours there was complete conversion of LC3-I to LC3-II in the 
parental and shControl cell line (figure 47).  However, in the shATG5 2 and 11 
cell lines there was no conversion despite the presence of the viral protein fiber. 
Therefore, similar to the mouse cell lines, ATG5 does play a role in adenovirus- 
mediated autophagy and deletion or knocking down ATG5 impairs autophagy 
induction. 
 
We subsequently analyzed lysis in these cell lines.  Further analysis with 
acridine orange revealed there was a 30% decrease in AVO positive cells 
between shControl and shATG5 11 (student’s t-test p=0.0005) (figure 52). 
Application of ethidium homodimer-1 revealed a 60.9±4.2% decrease in the 
number of lysed shATG511 cells compared to the shControl cell line (student’s t- 
test p=0.00326) (figure 51).  There 21.6±1.1% and 25.7±1.7% dead cells in the 
parental and shControl infected cells compared to 2.6±0.0% and 3.3±0.4% under 
mock conditions (student’s t-test p=0.001, p=0.0027 respectively). Deletion of 
ATG5 plays a significant role in AVO formation and cell lysis. 
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We performed a burst cell assay on these clones to identify whether lack 
of replication was important to cell lysis (figure 50).  Parental, shControl, and two 
shATG5  cell  lines  were  infected  at  100  MOI  for  one  hour,  the  media  was 
replaced and the supernatant was analyzed for E1A transcripts 24 hours later by 
quantitative-real time PCR. There was no statistical difference between the 
control and knockdown cell lines.  We also analyzed production of infectious viral 
progeny.  The two control and two knockdown cell lines were infected at 10 MOI 
and the cell lysates and supernatant were collected 72 hours post infection and 
analyzed  for  viral  particle  quantitation. There  was  no  statistical  difference 
between the control and knockdown cell lines, indicating replication was not 
compromised in these cells. 
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Figure 45: Infection of ATG5 Knockout MEFs Did Not Induce Autophagic Vacuole 
 
Formation.  Atg5 wild-type and Atg5 knockout MEFs were infected at 100 MOI for 
72 hours.  There were fixed and subjected to processing for electron microscopy. 
Arrows indicate autophagosomes. 
 
 
 
 
 
 
 
 
Figure 46: Infection of ATG5 Knockout MEFs Did Not Induce LC3 Cleavage. 
 
ATG5 wild-type and ATG5 knockout cells were infected as indicated and after 72 
hours  the  cells  were  subjected  to  Immunoblotting  for  virus  and  autophagy 
 
proteins. 
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Figure 47: Membrane Degradation was Decreased in ATG5 Null Cells Compared 
to Wild-type. Atg5 wild-type and Atg5 knockout mouse embryonic fibroblasts 
were infected as indicated for 72 hours and incubated with 8µM Ethidium 
Homodimer 1 for 15 minutes and analyzed by flow cytometry for cell membrane 
permeability 
 
 
 
 
 
 
 
 
 
Figure 48: Generation of an ATG5 Downregulated Cell Line. U87 cells were 
transfected with an shATG5 plasmid. Clones were chosen and assayed for 
ATG5 expression. 
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Figure 49: Cells with Downregulated ATG5 Failed to Cleave LC-3 After 
Adenovirus Infection. Cells were infected at 10 MOI for 72 hours and the protein 
was  collected  and  assayed  for  LC-3  cleavage  and  the  adenoviral  structural 
protein fiber. 
 
 
 
 
Figure  50:  Downregulation  of  ATG5  Led  to  Decreased  Acidic  Compartment 
 
Volume.  Cells were seeded in a 6-well plate and infected with Delta-24-RGD for 
 
48 hours.  Cells were analyzed by flow cytometry after acridine orange staining. 
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Figure  51:  Downregulation  of  ATG5  Decreased  Cell  Lysis. U87  Parental, 
shControl and shATG5 cells were infected at 10 MOI for 72 hours and incubated 
with 8µM Ethidium Homodimer 1 for 15 minutes and analyzed by flow cytometry 
for cell membrane permeability. 
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Figure 52: Downregulation of ATG5 Did Not Affect Viral Replication.   The U87 
parental, control, and shATG5 cells were infected with Delta-24-RGD at 100 MOI 
for 24 hours.  A) The media was collected and used at a template for E1A PCR 
to determine the number of E1A copies.  B) The supernatant and the cells were 
collected and subjected two 3 freeze thaw cycles.  The virus containing media 
was used for a hexon staining replication assay. 
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Chapter 4 
 
 
 
Conclusions 
 
 
1)  Infection with a replication-deficient virus failed to induce autophagosomes 
formation. 
 
 
 
2)  Replication deficient viruses, as opposed to replication competent, failed 
to induce cleavage of LC3 I to LC3 II and degradation of p62. 
 
 
 
3)  Cells infected with a replication competent adenovirus induced GFP-LC3 
punctuation. 
 
 
 
4)  Cells infected with a replication competent adenovirus increased the acidic 
compartment of the cell, correlating with autophagy. 
 
 
 
5)  Transient, exogenous expression of E1A did not increase LC3 conversion 
or increase p62 degradation. 
 
 
 
6)  Electron  Micrograph  studies  revealed  E1B55K,  E1B19K,  E3,  E4,  and 
 
VARNA mutant adenoviruses induce autophagy. 
 
 
 
 
7)  E1B55K,  E1B19K,  E3,  E4,  and  VARNA  mutant  adenoviruses  induced 
 
GFP-LC3 punctuation, thus correlating with autophagy. 
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8)  AKT was activated during virus infection. 
 
 
 
 
9)  Loss of AMPK had no effect on adenovirus-mediated autophagy. 
 
 
 
 
10) eIF2α phosphorylation correlated with p62 degradation after virus 
infection. 
 
 
 
11) Adenovirus did not upregulate ER-stress proteins. 
 
 
 
 
12) Loss of GCN2 rendered the cell resistant to adenovirus infection. 
 
 
 
 
13) Loss of GCN2 correlated with resistance to autophagy after adenovirus 
infection. 
 
 
14) In vivo infected wild-type mice underwent autophagy in the liver while 
 
GCN2 knockout mice failed to undergo autophagy. 
 
 
 
15) Livers of GCN2 knockout mice displayed twice as much necrosis and cell 
death compared to wild-type mice. 
 
 
16) Infection with adenoviruses increased the number of autophagic vacuoles 
and  Bafilomycin  decreasesd  the  turnover  over  autophagic  vacuoles 
without impairing replication. 
 
 
17) Lysis of the cell after adenoviral infection was a late process. 
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18) The use of autophagy inducers increased the size of viral plaques, while 
the autophagy inhibitor 3-MA reduced the size of plaques. 
 
 
19) ATG5 null MEFs and shATG5 cells failed to undergo autophagy and have 
decreased cell lysis. 
 
 
During this study we found that replication is not sufficient to induce 
autophagy and that only viruses that replicate can induce autophagy.  We 
found that, of the early genes tested, there was not one single gene that 
was responsible for the induction of autophagy however, evidence showed 
that E1B19K does contribute to adenovirus-mediated autophagy by 
interacting with Beclin1 and excluding BCL-2 from the PI3K-CIII-Beclin 1 
interactome.  Examination of the cellular pathways proved more promising 
in understanding the regulation of autophagy during adenovirus mediated 
autophagy. The  classical  starvation  pathway  of  autophagy  induction, 
AKT/mTOR, does not seem to play a role in adenovirus-mediated 
autophagy.  However,  the  intracellular  amino  acid  sensing  pathway, 
GCN2/eIF2α,  is  required  for  adenovirus  mediated  autophagy. Cells 
lacking GCN2 fail to undergo autophagy after adenovirus infection and are 
more viable in vitro. On the other hand, in the in vivo setting GCN2 
deficient mice are unable to cope with viral infection and their livers 
undergo more cell death.  We used this idea of autophagy and cell death 
and examined the role of autophagic cell death and lysis.  We found that 
cells unable to undergo autophagy through chemical inhibition or deletion 
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of crucial autophagy genes had impaired lysis; while cells that had 
increased autophagy flux through chemical manipulation underwent more 
autophagy. 
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Chapter 5 
 
 
 
Discussion 
 
 
The relationship between adenovirus and autophagy is relatively 
unexplored compared with that between other viruses and autophagy. Most 
papers have only reported that autophagy coexists in a cell infected with 
adenovirus or in conjunction with a therapeutic treatment (13, 27-30, 101). 
However, we believe that our results provide insight into the role of autophagy 
during adenovirus infections. Previous studies have shown that adenoviruses 
induce autophagy (13, 27-30, 101, 102); however, only LC3 conversion and 
increased Atg5/12 have been identified as biochemical markers.  In this study, 
we validated the changes in p62 observed in other autophagy studies (18); these 
changes may be useful as biochemical markers for autophagy during adenoviral 
infections  (69).  This  addition  to  the  overall  studies  with  adenovirus  and 
autophagy are beneficial because p62 degradation and addition of Bafilomycin A 
(103) can be used to monitor autophagy flux (11).  Therefore the functional 
output of autophagy can be studied. 
 
We began our studies examining whether infection alone was sufficient to 
induce autophagy. We proposed that adenovirus replication induces a hyper 
anabolic state the consumes large amounts of ATP and amino acids (32).  We 
found that infection alone was not sufficient to induce autophagy, therefore there 
must be role viral proteins play or the act of replication itself that induces 
autophagy.  To identify the specific role each early gene played we infected cells 
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deleted with each early gene. Of the early genes tested we were not able to 
definitively prove that loss of these proteins was responsible for autophagy 
induction.  No virus was completely devoid of the induction of autophagy.  Some 
viruses were attenuated, for example E1B19K, but the only virus that had a 
complete ablation of autophagy was the Delta-E1 virus, lacking E1A.  The caveat 
is that a virus deleted for E1A is also replication deficient.  Therefore we cannot 
separate the function of  E1A  for  the  cause  of  replication  or  its  functions  in 
inducing autophagy.  Exogenous restoration of E1A failed to induce autophagy, 
however this is a very artificial way to attempt to replicate the role of E1A within 
the cell.  It is possible that E1A corroborates with other viral proteins to exert its 
full function (47, 104). We believe further studies are needed that are able to 
examine the role E1A plays specifically in the context of autophagy induction. 
 
Because of the attenuated autophagy induction we decided to delve into 
the viral protein-cellular protein interaction of E1B19K and Beclin 1.  Yeast two 
hybrid screens had never shown E1B19K to interact with Beclin 1 (105). This is 
the first time that E1B19K has been shown to associate in a complex with Beclin 
1. Beclin 1 is a positive regulator of autophagy. We found that Beclin 1, 
E1B19K, and PI3K CIII all associate in a complex and remove BCL2 to induce 
autophagy. It  is  possible  that  E1B19K  stabilizes  the  complex  to  promote 
autophagy or E1B19K is involved in competitive binding with BCL2 to bind to 
Beclin 1. 
 
Although no single early gene appears to be required for autophagy 
induction we cannot rule out the interplay of two or more early genes to exert a 
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cellular function (47, 106).  Therefore further studies with the deletion of two or 
more viral proteins need to be done to fully examine the role viral proteins play in 
adenovirus-mediated autophagy. 
 
We also monitored the intracellular status of the cells to identify any 
changes that were related to autophagy pathways.  We proposed that the cells 
are in a hyperanabolic status during virus infection and we did, in fact, find a 
significant decrease in ATP. However, upon examination of the kinases that 
sense and regulate ATP levels we found no involvement in autophagy regulation 
during virus infection.  The lack of involvement of LKB1 and AMPK in autophagy 
regulation could be because their function is regulating protein translation during 
virus infection. 
 
The downstream effector in the AMPK pathway is mTOR (reviewed by 
(107)). mTOR is primarily known as a monitor of cell growth by controlling S6K1 
and 4E-BP1, and by regulating autophagy though via interaction with ULK1 (69). 
mTOR is activated by growth factors, AKT, and AMPK (reviewed by (107)). 
Generally speaking, autophagy is primarily known to be triggered through the 
AKT/PDK1/mTOR pathway (3).  We analyzed TSC2 within this pathway and did 
not find a requirement of TSC2 in adenovirus-mediated autophagy.  We also did 
not find the mTOR was inhibited during virus infection.  We found that AKT was 
only fully activated at 48 hours post infection.  Carloni et al reported an mTOR 
feedback loop activation of AKT in the presence of growth factor receptor 
stimulation(108) which is relevant to virus infection because O’Shea et al 2005 
reported that adenovirus mimics growth factor signals to activated mTOR (53, 
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109, 110).  We also found that p70S6K was phosphorylated throughout the 
experiment   and this contradicts the  phosphorylation status of mTOR. 
Nonetheless, it has been reported that E1A regulates phosphorylation of S6K1 
and 4E-BP1 independently of mTOR to facilitate viral replication (53, 111). 
Therefore more information is needed to clarify the role of mTOR by coupling or 
uncoupling the downstream substrates and identify their participation in protein 
translation inhibition and autophagy induction.  We believe that AKT pathway 
activation is more involved in protein translation for productive viral replication 
(53), however, these studies do not provide evidence for a role in the induction of 
autophagy.   Further  studies  are  warranted  to  understand  the  role  of  AKT 
activation during  adenovirus infection and the possibility of  an  mTOR 
independent mechanism. 
 
Basal levels of eIF2α phosphorylation under normal conditions is around 
 
5-10% (82-84).  25% of eIF2a was phosphorylated in the late stage of adenovirus 
infection (85).  eIF2α activation, upon adenovirus infection, has historically been 
attributed  to  PKR  activation,  despite  the  fact  adenovirus  employs  VA  RNA 
against  PKR,  25%  of  eIF2a  remains  phosphorylated. We  propose  that  the 
adenovirus neutralized PKR to inhibit an immune response, not to control 
translation.  In vitro phosphorylation assays revealed that activation of PKR and 
subsequent phosphorylation of PKR are not sufficient to halt protein translation, 
suggesting another alternative motive (85).  We too saw an increase in eIF2a 
phosphorylation and hypothesize that the purpose is to regulate autophagy. 
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Previous studies have described the relationship between herpes viruses 
and the regulation of autophagy through eIF2α pathway (66).  Tallóczy et al 
reported  the  GCN2  and  PKR  play  roles  in  starvation  and  virus  induced 
autophagy, respectively (66).  Since PKR does not play a role in eIF2a regulation 
during  adenovirus  infection  we  chose  not  to  examine  PKR  in  autophagy 
induction. Kouroku  et  at  2006  identified  that  polyQ  overexpression  lead  to 
increase of LC3 conversion and was ablated in eIF2α S51A Mefs and Atg5 KO 
MEFs along with an increase in ATG5/12 (67).  We also saw similar increase in 
LC3  conversion  and  ATG5/12  increase  during  adenovirus  infection  (13). 
However, we saw an unexpected decrease in the PERK-regulated chaperone 
folding proteins, if the cell were under ER stress we would expect the levels of 
 
expression to increase.  Therefore GCN2 seemed to be the prime candidate of 
examination. 
We  noted  that  cells  lacking  GCN2  were  rendered  resistant  to  the 
cytopathic effect of the virus and these cells were unable to undergo autophagy. 
We believed that the cells infected with adenovirus consumed large amounts of 
amino acids and the cell was able to activated GCN2 to respond to the decline in 
free amino acids, however when GCN2 is ablated, the cell has an impaired ability 
to sense the amino acids and fails to induce autophagy therefore impairing viral 
production. Mice  deficient  for  GCN2  fail  to  undergo  autophagy  in  the  liver 
suggesting that GCN2 does play a role in autophagy regulation during in vivo 
viral life cycle. We were surprised to see that the livers in GCN2 null mice 
underwent twice the amount of cell death in vivo and correlated with decreased 
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viability. We believe that autophagy is a protective mechanism and when the 
cells were not able to undergo autophagy in the in vivo niche the hepatocytes 
died by necrosis. 
Neither our studies, nor Tallóczy et al and Kouroku et al, identified a 
complete mechanism of the role eIF2α plays in the induction of autophagy (66, 
67).  A complete study of the eIF2α pathway is needed to isolate its involvement 
in adenovirus-mediated autophagy.  We believe the experiments here provide 
evidence  for  a  role  of  GCN2  during  adenovirus  infection. However,  more 
experiments  are  needed  to  identify  the  interplay  between  GCN2  and  the 
autophagy pathway.  GCN2 has been implicated during infection with Sindbis 
virus  where  GCN2  serves  as  an  inhibitory  molecule  of  viral  replication  by 
blocking  viral  translation  during  infection  (86). They  attributed  this  to  the 
increased  phosphorylation  of  eIF2α,  however  no  downstream  effectors  were 
analyzed. Ryzmski et al 2010 reported that bortezomib induces ER-stress and 
induces autophagy through an eIF2a/ATF4 dependent mechanism (87). 
Activating transcription factor 4 (ATF4) binds the cyclic AMP response element 
binding domain of LC3, leading to transcriptional upregulation (87, 88). The ATF4 
binding partner CHOP has been shown to bind and upregulate ATG5 (88). 
However, our transcriptional activation studies have not shown any increase in 
ATG5 or LC3 after virus infection (data not shown).  We postulate this could be 
due to the short turnover of the mRNAs, therefore an accumulation of mRNA is 
difficult to identify. 
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The relationship between autophagy and adenovirus-mediated cell lysis 
has yet to be fully examined.  We speculate that the generation of vacuoles in the 
cytoplasm destroys the intracellular and membrane integrity of the cell facilitating 
breakage of the membrane to aid in viral lysis.  Here, for the first time, we show 
that autophagy plays an essential role in the process of cell lysis induced by 
adenovirus. 
In the past there are three main viral proteins that have been the focus of 
mediating viral cell lysis. The L3 viral protease cleaves cytokeratin K18 and 
promoting lysis . There are a few reports suggesting that viral proteins regulate 
the cell lysis process (112). The E3 11.6-kD adenovirus death protein (ADP), 
aids in the destruction of the nuclear membrane and release of progeny virions 
(50, 51). Overexpression of ADP was shown to increase oncolysis by 
adenoviruses (113). It is unknown whether these two proteins play a role in the 
regulation of autophagy. 
Nevertheless, our data clearly demonstrate that autophagy plays an 
essential  role  in  adenovirus-mediated  cell  lysis.  Treatment  of  cells  with 
autophagy inducers increases the size of plaques which one can attribute to cell 
lysis, while treatment with 3-MA, an autophagy inhibitor, decreases the area of 
plaques.  Consistent with the above observations, knockout or downmodulation 
of the key autophagy gene ATG5 substantially impairs the ability of the virus to 
induce lysis of host cells.  Thus, there is a cause-and-effect relationship between 
autophagy  and cell lysis.  This  suggests  that autophagy,  a  highly  genetically 
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programmed cellular process, is a candidate target whose manipulation might 
improve the efficiency of oncolytic adenovirus to induce lysis in cancer cells. 
Our results here also provide a mechanistic rationale for our previous 
reports showing that rapamycin has a synergistic effect with oncolytic 
adenoviruses and strongly suggest that rapamycin-enhanced oncolytic potency is 
due to facilitation of autophagy (28). These findings offer a rationale for the 
combination of autophagy inducing drugs and oncolytic adenoviruses to enhance 
glioma  treatment.  In  this  regard,  the  gold  standard  for  glioma  treatment, 
temozolomide, induces autophagy and has synergistic effects with oncolytic 
adenoviruses (27). 
In summary, we demonstrate here that GCN2 plays a significant role in 
the regulation of adenovirus-mediated autophagy and that autophagy plays an 
indispensable role in adenovirus-mediated cell lysis. Our study provides a new 
mechanism for adenovirus-induced cell lysis through which strategies can be 
imposed to improve oncolytic adenoviral potency in cancer therapy. 
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